Cargando…

Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients

Objective: To evaluate prevalence of metabolic syndrome in hypertensive type 2 diabetic patients treated with antihypertensive drugs that inhibit renin angiotensin system. Methodology: Two groups of patients were included in this study. The first group involved 130 hypertensive type 2 diabetic patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmood, Isam Hamo, Abed, Mohammed Najim, Merkhan, Marwan Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publicaitons 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809179/ https://www.ncbi.nlm.nih.gov/pubmed/24353526 http://dx.doi.org/10.12669/pjms.291.2782

Ejemplares similares

Antagonism of Bcl-X(L) is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
por: Abed, Mohammed Najim, et al.
Publicado: (2016)

Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells
por: Abdullah, Marwan Ibrahim, et al.
Publicado: (2017)

Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death
por: Abdullah, Marwan Ibrahim, et al.
Publicado: (2019)

Physoxia alters human mesenchymal stem cell secretome
por: Merkhan, Marwan M, et al.
Publicado: (2021)

Human Mesenchymal Stem Cell Secretome Driven T Cell Immunomodulation Is IL-10 Dependent
por: Shephard, Matthew T., et al.
Publicado: (2022)

Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel
por: Ibrahim, Suad Lateef, et al.
Publicado: (2022)

Sympathoexcitation Associated with Renin-Angiotensin System in Metabolic Syndrome
por: Kishi, Takuya, et al.
Publicado: (2013)

Vitamin D and Immunoglobulin E Status in Allergic Rhinitis Patients Compared to Healthy People
por: Alnori, Haitham, et al.
Publicado: (2020)

Additive Interaction Between the Renin-Angiotensin System and Lipid Metabolism for Cancer in Type 2 Diabetes
por: Yang, Xilin, et al.
Publicado: (2009)

Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA
por: Joseph, Joshua J., et al.
Publicado: (2018)

Impact of Metabolic Syndrome Factors on Testosterone and SHBG in Type 2 Diabetes Mellitus and Metabolic Syndrome
por: Mohammed, Mukhtar, et al.
Publicado: (2018)

The Effects of Blocking Angiotensin Receptors on Early Stages of Diabetic Nephropathy
por: Gheissari, Alaleh, et al.
Publicado: (2012)

Prevalence of metabolic syndrome in type 2 diabetes mellitus patients
por: Nsiah, Kwabena, et al.
Publicado: (2015)

Activation of the renin-angiotensin system in high fructose-induced metabolic syndrome
por: Kim, Mina, et al.
Publicado: (2020)

Autophagy in metabolic syndrome: breaking the wheel by targeting the renin–angiotensin system
por: Menikdiwela, Kalhara R., et al.
Publicado: (2020)

The role of the renin–angiotensin system blocking in the management of atrial fibrillation
por: Cliff, Brett, et al.
Publicado: (2012)

The Impact of Diabetes Mellitus Duration and Complications on Health-Related Quality of Life Among Type 2 Diabetic Patients in Khamis Mushit City, Saudi Arabia
por: Alshahrani, Jaber Abdullah, et al.
Publicado: (2023)

Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
por: Silhol, François, et al.
Publicado: (2020)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
por: Kang, Si-Hyuck, et al.
Publicado: (2021)

Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase
por: Ichikawa, Mai, et al.
Publicado: (2014)

The renin–angiotensin system and diabetes: An update
por: Ribeiro-Oliveira, Antônio, et al.
Publicado: (2008)

Prevalence, characteristics and risk factors of diabetic retinopathy in type 2 diabetes mellitus patients in Jordan: a cross-sectional study
por: Roto, Allaa, et al.
Publicado: (2022)

Effect of the renin-angiotensin system on the exacerbation of adrenal glucocorticoid steroidogenesis in diabetic mice: Role of angiotensin-II type 2 receptor
por: Chaves, Amanda da Silva, et al.
Publicado: (2022)

Responses to Dehydration in the One-Humped Camel and Effects of Blocking the Renin-Angiotensin System
por: Ali, Mahmoud Alhaj, et al.
Publicado: (2012)

A Comparative Prevalence Of Metabolic Syndrome Among Type 2 Diabetes Mellitus Patients In Hawassa University Comprehensive Specialized Hospital Using Four Different Diagnostic Criteria
por: Bizuayehu Wube, Temesgen, et al.
Publicado: (2019)

Family history of type 2 diabetes and prevalence of metabolic syndrome in adult Asian Indians
por: Das, Mithun, et al.
Publicado: (2012)

High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome
por: Hirata, Ayumu, et al.
Publicado: (2012)

Evaluation of the Pharmacologic Treatment of COVID-19 Pandemic in Iraq
por: Darweesh, Omeed, et al.
Publicado: (2021)

Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study
por: Hamida, Mohammed Elfatih, et al.
Publicado: (2021)

Metabolic Syndrome in Patients With Diabetes Mellitus
por: Essafi, Mohammed Amine, et al.
Publicado: (2022)

Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System
por: Moore, Graham J., et al.
Publicado: (2022)

Interactions Among Related Genes of Renin-Angiotensin System Associated With Type 2 Diabetes
por: Yang, Jin-Kui, et al.
Publicado: (2010)

Effects of blood pressure and the renin‐angiotensin system on platelet activation in type 2 diabetes
por: Uzu, Takashi, et al.
Publicado: (2010)

Renin-Angiotensin System Gene Variants and Type 2 Diabetes Mellitus: Influence of Angiotensinogen
por: Joyce-Tan, Siew Mei, et al.
Publicado: (2016)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016)

Relation Between Renin–Angiotensin–Aldosterone System Inhibitors and COVID-19 Severity
por: Alhaddad, Mousa J, et al.
Publicado: (2022)

Association of polymorphisms within the Renin-Angiotensin System with metabolic syndrome in a cohort of Chilean subjects
por: Herrera, Christian L., et al.
Publicado: (2016)

Sex differences in the metabolic effects of the renin-angiotensin system
por: White, Melissa C., et al.
Publicado: (2019)

The prevalence of celiac disease in Saudi patients with type 1 diabetes mellitus
por: Aljulifi, Mohammed Zaid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0fnq0dbjok7mefvlnnjfiul09m